Literature DB >> 12441802

Primary HIV-1 infection in African children infected through breastfeeding.

François Rouet1, Narcisse Elenga, Philippe Msellati, Crépin Montcho, Ida Viho, Charlotte Sakarovitch, Christine Danel, Christine Rouzioux, Valériane Leroy, François Dabis.   

Abstract

OBJECTIVES: To describe acute retroviral syndrome and associated primary viraemia in African children infected with HIV-1 through breastfeeding.
DESIGN: Matched case-control study performed retrospectively within the ANRS 049 DITRAME project conducted in 1995-1998 in Abidjan, Côte d'Ivoire.
METHODS: Cases were children infected by HIV-1 postnatally through breastfeeding. All were HIV-1 negative by DNA PCR at least 45 days of age, but positive on a subsequent sample. This period was considered as surrounding the estimated date of postnatal contamination. Signs/symptoms occurring within this period were recorded in cases and compared with those occurring during the same time period in uninfected breastfed children (controls). For cases, plasma specimens were tested for HIV-1 plasma RNA using the branched DNA assay.
RESULTS: Of 22 infants infected postnatally (median age at first positive sample, 185 days; range, 87-373 days), 21 (95.5%) exhibited at least one clinical sign, compared with only 27 of the 44 (61.4%) uninfected children (P = 0.003). Three independent factors were associated with primary HIV-1 infection: mononucleosis-like syndrome [odds ratio (OR), 8.3; 95% confidence interval (CI), 1.4-47.8], dermatitis (OR, 6.0; CI, 1.1-31.9), and generalized lymphadenopathy (OR, 26.5; CI, 2.0-348.4). Among cases, initial median plasma HIV-1 RNA viral load was 5.92 log10 copies/ml; this declined to 4.96 log10 12 months after the first positive viral load.
CONCLUSIONS: These results may be useful for the recognition of early paediatric cases of postnatal transmission in Africa and could enable targeting of those who should benefit from HIV RNA or DNA testing for primary HIV-1 infection and their subsequent care. Copyright 2002 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441802     DOI: 10.1097/00002030-200211220-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti.

Authors:  Erik George; Carole Anne Beauharnais; Emilio Brignoli; Francine Noel; Gyrlande Bois; Patricia De Matteis Rouzier; Martine Altenor; Daniel Lauture; Marlène Hosty; Sapna Mehta; Peter F Wright; Jean W Pape
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

Review 2.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

3.  Acute HIV infection among Kenyan infants.

Authors:  Barbra A Richardson; Ruth Nduati; Dorothy Mbori-Ngacha; Julie Overbaugh; Grace C John-Stewart
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

4.  Primary HIV-1 infection among infants in sub-Saharan Africa: HPTN 024.

Authors:  Jennifer S Read; Anthony Mwatha; Barbra Richardson; Megan Valentine; Lynda Emel; Karim Manji; Irving Hoffman; Usha Sharma; Robert L Goldenberg; Taha E Taha
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

5.  Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study.

Authors:  Heather B Jaspan; Landon Myer; Shabir A Madhi; Avy Violari; Diana M Gibb; Wendy S Stevens; Els Dobbels; Mark F Cotton
Journal:  BMC Pediatr       Date:  2011-11-21       Impact factor: 2.125

6.  Retroviral rebound syndrome after treatment discontinuation in a 15 year old girl with HIV attracted through mother-to-child transmission: case report.

Authors:  Vanda Friman; Magnus Gisslén
Journal:  AIDS Res Ther       Date:  2007-02-23       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.